Q32 Bio Inc (QTTB) News

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 8-K - Current report

Q32 Bio Announces Completion of Enrollment in the SIGNAL-AD Phase 2 Clinical Trial of Bempikibart for Atopic Dermatitis

Q32 Bio Announces Completion of Enrollment in the SIGNAL-AD Phase 2 Clinical Trial of Bempikibart for Atopic...

Q32 Bio Joins Russell 3000® Index

Q32 Bio Joins Russell 3000® Index PR Newswire WALTHAM, Mass., July 1, 2024 WALTHAM, Mass., July 1, 2024...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update

Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update PR Newswire WALTHAM, Mass...

Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer

Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer PR Newswire WALTHAM, Mass., April 3...